Latest California Healthline Stories
Podcast: KHN’s ‘What The Health?’ The ACA Heads Back To Court. Again.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and Sarah Kliff of Vox discuss the latest lawsuit challenging the constitutionality of the Affordable Care Act. They also explore how your health care system increasingly depends on the state you live in. Plus, for extra credit, the panelists offer their favorite health policy stories of the week.
Podcast: KHN’s ‘What The Health?’ The Long Wait Ends For Short-Term Plan Rules
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Margot Sanger-Katz of The New York Times, Stephanie Armour of The Wall Street Journal and Julie Appleby of Kaiser Health News discuss the Trump administration’s proposed regulation that would allow the expansion of short-term health insurance policies that do not comply with all the requirements of the Affordable Care Act. The panelists also talk about federal funding (or not) of public health research around guns.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Margot Sanger-Katz of The New York Times, Stephanie Armour of The Wall Street Journal and Paige Winfield-Cunningham of The Washington Post discuss President Donald Trump’s budget plan and how some states are trying to stabilize the Affordable Care Act, while others are trying to violate it. Also, Rovner and KHN’s Sarah Jane Tribble interview Scott Gottlieb, commissioner of the Food and Drug Administration.
Podcast: KHN’s ‘What The Health?’ There’s A Really Big Health Bill In That Budget Deal
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Alice Ollstein of Talking Points Memo, Joanne Kenen of Politico and Margot Sanger-Katz of The New York Times discuss the health policy changes included in the just-concluded bipartisan budget deal on Capitol Hill. The panelists also talk about the final enrollment numbers for individual insurance purchased under the Affordable Care Act, and possible drug price proposals in President Donald Trump’s upcoming budget. Plus, Rovner interviews Andy Slavitt, who this week launched a health care advocacy group called “The United States of Care.”
Centros comunitarios de salud obtienen fondos a largo plazo
Como parte de la legislación para no cerrar el gobierno federal, estos centros que reciben a 27 millones de personas cada año en todo el país tendrán dinero por dos años.
Bipartisan Senate Budget Deal Boosts Health Programs
The agreement would add $2 billion to the National Institutes of Health and fund community health centers around the country. But it does not include provisions to help stabilize the federal health law’s marketplaces.
Community Health Centers Caught In ‘Washington’s Political Dysfunction’
Without action by Congress, federal funding for the centers will end March 31. California, with more than 1,300 centers providing care for 6.5 million people, will be hit hard if the money dries up. Nationwide, nearly 10,000 centers serve 27 million people and get about 20 percent of their funding from the federal government.
Stalled Health Programs Await A Green Light On The Hill
With another piece of must-pass legislation set to move through Congress, there’s a push to attach provisions to keep afloat a number of health-related programs for which funding or specific federal direction has expired.
Podcast: ‘What The Health?’ CHIP (Finally) Gets Funded
In this episode of “What The Health?” Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Alice Ollstein of Talking Points Memo and Paige Winfield Cunningham of The Washington Post discuss the short-term spending bill passed by Congress that reopened the federal government and funded the Children’s Health Insurance Program for six years. The panelists also discussed the health programs still awaiting funding, and the intersection of religion and women’s health services at the Department of Health and Human Services.
Big Pharma Greets Hundreds Of Ex-Federal Workers At The ‘Revolving Door’
A KHN data analysis finds that the door of opportunities connecting Capitol Hill, the federal government and the drug industry likely spins in Big Pharma’s favor.